Clinical Trials
202 trialsSOS4C
Mayo Clinic
TNT Esophagus
Duke University
Futibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Northwestern University
A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer
Memorial Sloan Kettering Cancer Center
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Alliance for Clinical Trials in Oncology
Minimally Invasive Molecular Approaches for the Detection of Barrett's Esophagus- High Grade Dysplasia and Esophageal Adenocarcinoma
Mayo Clinic
GRACIE
UNICANCER
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
University of Pittsburgh
Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal Junction
Brown University
Minimally Invasive Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Cancer, SOS5C Trial
Mayo Clinic
PSI-Immune
University of Pittsburgh
Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer
M.D. Anderson Cancer Center
SLURP
University Medical Center Groningen
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
University of Chicago
TOSS pilot
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
ablation IN BE
Mayo Clinic
OLIGOMETS
Yale University
Endeavor-1
University Hospital, Antwerp
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
Memorial Sloan Kettering Cancer Center
Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer
Institut du Cancer de Montpellier - Val d'Aurelle
OPTIMUS
University of Surrey
ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu
University of California, Irvine
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
Mayo Clinic
CAMILLA
University of Pittsburgh
FEO
Société Française d'Endoscopie Digestive
Induction FLOT With CROSS CRT for Esophageal Cancer
University of Colorado, Denver
Impact of Arterial Partial Pressure of Oxygen on Anastomotic Leakage After Esophagectomy
Sun Yat-sen University
TNT-OES-2
Erasmus Medical Center
NeoTISLEGA
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Barrett's Esophagitis in Anorexia Nervosa Binge/Purge Subtype
Denver Health and Hospital Authority
AROMA2
Imperial College London
SURVENT
University of Colorado, Denver
Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
Case Comprehensive Cancer Center
Liquid Nitrogen Spray Cryotherapy Prior to Neoadjuvant Systemic Therapy in Esophageal Adenocarcinoma
Case Comprehensive Cancer Center
SCREEN-BE
University of Colorado, Denver
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
University of California, San Francisco
RATE
Centre of Postgraduate Medical Education
SEISMIC
Guy's and St Thomas' NHS Foundation Trust
Durvalumab, an Anti-PDLI Antibody, and Tremelimumab, an Anti-CTLA4 Antibody, and Chemoradiation Before Surgery for Esophageal Cancer
Memorial Sloan Kettering Cancer Center
Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer
City of Hope Medical Center
MEMENTO
Amsterdam UMC, location VUmc
TRACT DNA
Medical College of Wisconsin
The Microbiome, Bile Acids, and Notch in Barrett's Esophagus (BE)
Columbia University
ATTENUATION
Centre Leon Berard
OPPOSITE
University Hospital Heidelberg
ACROPOLI
SOLTI Breast Cancer Research Group
LABS
Imperial College London
MAGnET
Royal Marsden NHS Foundation Trust
Oncometabolome and MALDI-MSI in Upper GI Carcinomas - Chemosensitivity in Esophageal Carcinoma
Ludwig-Maximilians - University of Munich
REACT
Columbia University